v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income (loss) $ 3,214,790 $ (2,689,821)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Stock-based compensation 50,788 98,619
Provision for credit losses (196,619) (9,433)
Depreciation and amortization 1,657,291 1,652,331
Amortization of premium (1,883,841) (1,883,841)
Gain on dispositions (12,461,477) (1,698,228)
Deferred income taxes 1,242,777 (1,570,339)
Equity in earnings of unconsolidated affiliates (28,919) (26,198)
Change in operating assets and liabilities:    
Accounts receivable 5,597,853 5,256,224
Prepaid expenses 615,829 809,716
Other assets (1,747,062) (928,464)
Accounts payable (4,422,692) (3,082,509)
Other liabilities 4,515,159 746,272
Other operating activities 361,690 (148,834)
Net cash used in operating activities (3,484,433) (3,474,505)
Cash flows from investing activities:    
Capital expenditures (650,778) (800,165)
Proceeds from dispositions 19,319,709 2,746,507
Net cash provided by investing activities 18,668,931 1,946,342
Cash flows from financing activities:    
Payments of debt (18,694,000) 0
Purchase of treasury stock (1,735) (9,105)
Net cash used in financing activities (18,695,735) (9,105)
Net decrease in cash and cash equivalents (3,511,237) (1,537,268)
Cash and cash equivalents at beginning of period 9,936,783 13,772,720
Cash and cash equivalents at end of period 6,425,546 12,235,452
Cash paid for interest 2,135,682 6,592,232
Cash paid for income taxes $ 18,060 $ 112,450